AstraZeneca fights back in cancer with new hires, fast drug status

LONDON (Reuters) – AstraZeneca hired two senior scientists to bolster its cancer drug work on Monday, signaling confidence in its oncology portfolio despite last week’s big setback in a lung cancer clinical trial.

Leave a Reply

Your email address will not be published. Required fields are marked *